2,3-Diethyl-5-methylpyrazine
Common Name: |
2,3-Diethyl-5-methylpyrazine |
IUPAC Name: |
2,3-diethyl-5-methylpyrazine |
Molecular Formula: |
C9H14N2 |
SMILES: |
CCC1=NC=C(N=C1CC)C |
Inchi: |
1S/C9H14N2/c1-4-8-9(5-2)11-7(3)6-10-8/h6H,4-5H2,1-3H3 |
Inchi Key: |
PSINWXIDJYEXLO-UHFFFAOYSA-N |
Cas No: |
18138-04-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
150.22 |
Mass (g/mol) |
150.115698 |
Molar Refractivity |
46.54 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
25.78 |
Hetero Atoms |
2 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
191.00 to 193.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.515 |
Vapor Density (Air =1) |
5.2 |
Fraction Csp3 |
0.56 |
LogP |
1.91 |
iLOGP |
2.23 |
XLOGP3 |
1.85 |
WLOGP |
1.91 |
MLOGP |
0.87 |
ESOL Log S |
-2.21 |
ESOL Solubility (mg/ml) |
0.929 |
ESOL Solubility (mol/l) |
0.006 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.01 |
Ali Solubility (mg/ml) |
1.46 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.60 |
Silicos-IT Solubility (mg/ml) |
0.04 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.90 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.593 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.885 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |